Replies to post #141300 on Biotech Values

[DewDiligence]

EXAS—The rationale in this instance is that finding patients >65 who have not had a colonoscopy in the past 9 years is difficult.

Yes, we discussed this a few months ago in response to a quiz question (#msg-72466826). My comments in #msg-75190568 addressed not the problem, but rather the intended solution—doling out about $5M of bonus money to the centers in the DEEP-C study. How exactly does this extra money bring in more patients age 65 and over?

[DewDiligence]

EXAS—In previous versions of the test methylation assays failed because they were detecting age-related changes and not cancer related changes.

Can you elaborate on this? T.i.a.